» Articles » PMID: 17558337

HIV-positive Patients with Nonalcoholic Fatty Liver Disease Have a Lower Body Mass Index and Are More Physically Active Than HIV-negative Patients

Overview
Date 2007 Jun 15
PMID 17558337
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether the clinical and metabolic features associated with nonalcoholic fatty liver disease (NAFLD) are similar between HIV-positive and HIV-negative male subjects.

Methods: Twenty-six HIV-positive and 25 HIV-negative subjects with liver biopsy-proven NAFLD were compared for liver histology (extent of steatosis, steatosis grading, and fibrosis staging), blood biochemistry (glucose, insulin, C-peptide, hemoglobin A1c, and lipid profile), insulin resistance (IR) using a homeostasis model assessment, anthropometry (body mass index [BMI], waist circumference, and arm muscle area), dietary intake, and physical activity.

Results: The 2 groups were similar for age, liver histology, and IR. HIV-positive patients had a lower BMI (26.3 +/- 0.5 vs. 30.2 +/- 1.0 kg/m; P = 0.001) and lower percentage of fat mass (19.4 +/- 0.9 vs. 22.7 +/- 1.2; P = 0.026) when compared with HIV-negative patients. Although caloric intake was similar between groups, HIV-positive patients had a higher physical activity level (8.3 +/- 1.6 vs. 4.1 +/- 0.8 units of exercise per day; P = 0.029). Blood triglycerides were significantly higher (3.14 +/- 0.39 vs. 1.86 +/- 0.20 mmol/L; P = 0.006) in HIV-positive patients.

Conclusion: Although NAFLD was similar between the 2 groups, HIV-positive patients had a lower BMI and were more physically active compared with HIV-negative patients. This may suggest that in HIV, NAFLD is associated with factors other than those related to body fatness, such as HIV infection and treatment.

Citing Articles

MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls.

Allende D, Cummings O, Sternberg A, Behling C, Carpenter D, Gill R Aliment Pharmacol Ther. 2024; 60(10):1351-1360.

PMID: 39238213 PMC: 11499004. DOI: 10.1111/apt.18236.


Liver Steatosis is Prevalent in Lean People With HIV and Associated With Exposure to Antiretroviral Treatment-A Cross-sectional Study.

van Eekeren L, Vadaq N, Vos W, Blaauw M, Groenendijk A, van Lunzen J Open Forum Infect Dis. 2024; 11(6):ofae266.

PMID: 38868310 PMC: 11167668. DOI: 10.1093/ofid/ofae266.


The Potential of Clostridium butyricum to Preserve Gut Health, and to Mitigate Non-AIDS Comorbidities in People Living with HIV.

Yang Q, Zaongo S, Zhu L, Yan J, Yang J, Ouyang J Probiotics Antimicrob Proteins. 2024; 16(4):1465-1482.

PMID: 38336953 DOI: 10.1007/s12602-024-10227-1.


Changes in Body Mass Index Over Time in People With and Without HIV Infection.

Lam J, Leyden W, Alexeeff S, Lea A, Hechter R, Hu H Open Forum Infect Dis. 2024; 11(2):ofad611.

PMID: 38323078 PMC: 10846771. DOI: 10.1093/ofid/ofad611.


The pathogenesis of obesity in people living with HIV.

Bailin S, Koethe J, Rebeiro P Curr Opin HIV AIDS. 2023; 19(1):6-13.

PMID: 37934696 PMC: 10842175. DOI: 10.1097/COH.0000000000000834.